Summary
November 2007, Vol. 8, No. 16, Pages 2757-2774 , DOI 10.1517/14656566.8.16.2757

Pharmacotherapy for allergic contact dermatitis

Sharon E Jacob1 & Mari Paz Castanedo-Tardan
1University of Miami, Leonard M. Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Florida 33124, USA
Author for correspondence



Allergic contact dermatitis is a highly prevalent, potentially chronic disease, with a significant economic and quality of life impact. Culprit causal allergen(s) can be identified though patch testing, the ‘gold-standard’ diagnostic method. For most people, identification and subsequent avoidance of their clinically relevant allergens will results in resolution of the dermatitis. However, when an avoidance regimen is not possible, or an allergen is not identified, patients potentially require symptomatic and immunosuppressive therapy to diminish the manifestations of their disease. This article reviews a therapeutic approach to allergic contact dermatitis.

Full Text | PDF (195 KB) | PDF Plus (361 KB)

Forward Links to Citing Articles

Mari Paz Castanedo-Tardan, Mercedes E. González, Elizabeth A. Connelly, Kelly Giordano, Sharon E. Jacob. (2009) Systematized Contact Dermatitis and Montelukast in an Atopic Boy. Pediatric Dermatology
Online publication date: 1-Apr-2009.
CrossRef
 

Prev. Article | Next Article
View/Print PDF (195 KB)
View PDF Plus (361 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Authors:
Sharon E Jacob
Mari Paz Castanedo-Tardan
Keywords:
allergic contact dermatitis
systemic
topical
treatment